Harnett Samantha sold $1.6M of LOGI

Logitech (LOGN) reported Q2 sales of $1.22B, GAAP EPS $1.25, with strong mice/keyboard growth and 45.2% adj. gross margin. Q3 guidance is $1.36–$1.43B, but a $70–$80M supplier shortfall is expected. Regional demand varied, with Americas up 13% and Asia-Pacific/EMEA down. Travel was halted due to cautious business conditions.

Morgan Stanley maintained an Underweight rating for Logitech (LOGI) but raised its price target to $94 from $90. GuruFocus values LOGI at $101.09, suggesting a 3.1% undervaluation. Insider selling and mixed analyst sentiment indicate caution.

Logitech reported fiscal Q2 net income of $180M, or $1.25 per share, exceeding analyst expectations of $1.34 per share. Revenue was $1.22B, surpassing forecasts of $1.21B. The company expects Q3 revenue between $1.36B and $1.43B.

The Swiss market closed slightly down, with the SMI index falling 0.11% to 14,581.10. Logitech shares dropped 11% after warning of supply constraints impacting Q3 sales, despite beating Q2 earnings estimates.

Logitech (LOGI) shares fell 11.12% to $99.39 on October 28 due to a supplier disruption expected to reduce Q3 revenue by $70M-$80M. Despite Q2 sales growth of 3% to $1.22B and EPS growth of 4% to $1.51, the supply issue impacts holiday sales. Management expects full production recovery by year-end.

Wendy's rose 15% on a $1.4B privatization proposal from Trian Fund. Brinker International and Wingstop gained 15% after raising guidance and beating earnings. F5 dropped 19% on weak guidance and a downgrade. Labcorp and GE HealthCare advanced on raised guidance. Ultralife surged 145% on a $320M acquisition deal. Enphase Energy fell 16% on missed revenue. PPG Industries rose 6% on earnings beat and raised guidance. Robinhood fell 2% on missed profit. SK hynix advanced 11% on strong earnings.